| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SELECT SECTOR SPDR TR SBI HEALTHCARE | 10,000 | 66,230,000 | 8.45% | Put | |
| 2 | ALLERGAN PLC | 177,100 | 48,138,000 | 6.14% | ||
| 3 | SPDR S&P 500 ETF TR PUT | 2,451 | 46,969,000 | 5.99% | Put | |
| 4 | TEVA PHARMACEUTICAL INDS LTD | 752,905 | 42,509,000 | 5.42% | ||
| 5 | SPDR S&P BIOTECH ETF | 6,000 | 37,350,000 | 4.77% | Put | |
| 6 | ISHARES TR | 1,000 | 30,333,000 | 3.87% | Put | |
| 7 | ELBIT SYS LTD | 100,618 | 29,169,000 | 3.72% | ||
| 8 | BIOGEN INC | 85,000 | 24,804,000 | 3.16% | ||
| 9 | PFIZER INC | 574,013 | 18,030,000 | 2.30% | ||
| 10 | ABBVIE INC | 327,000 | 17,792,000 | 2.27% | ||
| 11 | ORMAT TECHNOLOGIES INC | 132,659 | 17,551,000 | 2.24% | ||
| 12 | SHIRE PLC | 169,751 | 13,252,000 | 1.69% | ||
| 13 | BIOMARIN | 125,000 | 13,165,000 | 1.68% | ||
| 14 | CELGENE CORP | 120,000 | 12,980,000 | 1.66% | ||
| 15 | MYLAN N.V. | 3,000 | 12,078,000 | 1.54% | Call | |
| 16 | GILEAD SCIENCES INC | 120,000 | 11,783,000 | 1.50% | ||
| 17 | INCYTE | 100,000 | 11,033,000 | 1.41% | ||
| 18 | CLOVIS ONCOLOGY INC | 105,000 | 9,656,000 | 1.23% | ||
| 19 | BRISTOL MYERS SQUIBB CO | 150,000 | 8,880,000 | 1.13% | ||
| 20 | CELLCOM ISRAEL LTD | 357,452 | 8,793,000 | 1.12% | ||
| 21 | PERRIGO CO PLC | 547 | 8,603,000 | 1.10% | Call | |
| 22 | MYLAN N V | 200,000 | 8,052,000 | 1.03% | ||
| 23 | ACORDA THERAPEUTICS | 270,000 | 7,158,000 | 0.91% | ||
| 24 | AMGEN INC | 50,200 | 6,944,000 | 0.89% | ||
| 25 | HORIZON PHARMA PLC | 3,500 | 6,937,000 | 0.89% | Call | |
| 26 | DEPOMED INC | 360,000 | 6,786,000 | 0.87% | ||
| 27 | SELECT SECTOR SPDR TR | 89,216 | 6,625,000 | 0.85% | ||
| 28 | VANDA PHARMACEUTICALS INC COM | 513,390 | 5,791,000 | 0.74% | ||
| 29 | CHECK POINT SOFTWARE TECH LT | 72,327 | 5,738,000 | 0.73% | ||
| 30 | ALEXION PHARMACEUTIC | 35,000 | 5,474,000 | 0.70% | ||
| 31 | TESARO INC | 117,500 | 4,712,000 | 0.60% | ||
| 32 | AMICUS THERAPEUTICS INC | 310,000 | 4,337,000 | 0.55% | ||
| 33 | Egalet Corp | 325,000 | 4,284,000 | 0.55% | ||
| 34 | PTC THERAPEUTICS INC | 1,600 | 4,272,000 | 0.55% | Call | |
| 35 | INTRA CELLULAR THERAPIES INC COM | 105,400 | 4,220,000 | 0.54% | ||
| 36 | VERTEX PHARMACEUT | 40,000 | 4,166,000 | 0.53% | ||
| 37 | ALDER BIOPHARMACEUTICALS INC | 125,000 | 4,095,000 | 0.52% | ||
| 38 | PORTOLA PHARMACEUTICALS INC | 95,000 | 4,049,000 | 0.52% | ||
| 39 | HORIZON PHARMA PLC | 200,000 | 3,964,000 | 0.51% | ||
| 40 | KEMPHARM INC | 204,393 | 3,961,000 | 0.51% | ||
| 41 | GW PHARMACEUTICALS PLC | 43,100 | 3,938,000 | 0.50% | ||
| 42 | UNITED THERAPEUTICS | 28,840 | 3,785,000 | 0.48% | ||
| 43 | CONCERT PHARMACEUTICALS INC COM | 200,000 | 3,754,000 | 0.48% | ||
| 44 | MACROGENICS INC | 170,000 | 3,641,000 | 0.46% | ||
| 45 | STARBUCKS CORP | 62,683 | 3,563,000 | 0.45% | ||
| 46 | RAPTOR PHARMACEUTICAL CORP | 584,089 | 3,534,000 | 0.45% | ||
| 47 | ARRAY BIOPHARMA INC | 7,500 | 3,420,000 | 0.44% | Call | |
| 48 | AMAG PHARMACEUTICALS INC COM | 85,230 | 3,386,000 | 0.43% | ||
| 49 | BELLICUM PHARMACEUTICALS INC COM | 231,514 | 3,364,000 | 0.43% | ||
| 50 | CATALYST PHARMACEUTICALS INC | 1,100,000 | 3,300,000 | 0.42% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-15-003433, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
